Ondine Biomedical

Ondine Biomedical Inc. is a biotechnology company headquartered in Vancouver, Canada, specializing in the research, development, and commercialization of non-antibiotic therapies for bacterial, fungal, and viral infections using its proprietary Photodisinfection technology. This light-activated technology offers antimicrobial efficacy while minimizing the risk of antibiotic resistance. Ondine's primary product, Periowave, is an adjunctive therapy for chronic adult periodontitis. The company also develops other applications, including the MRSAid Photodisinfection system for decolonizing methicillin-resistant Staphylococcus aureus, Endowave for eradicating bacterial biofilms in endotracheal tubes, and Vitalwave for decolonizing the birth canal to prevent vertical transmission of pathogens. Additionally, Ondine collaborates with Sinuwave Technologies Corporation to advance therapies for chronic sinusitis. The company was previously known as Ondine Biopharma Corporation until its name change in 2010.